Zest Pharma — Secnidazole Exporter Profile
Indian Pharmaceutical Exporter · #11 for Secnidazole · $192.9K export value · DGFT Verified
Zest Pharma is the #11 Indian exporter of Secnidazole with $192.9K in export value and 14 verified shipments. Zest Pharma holds a 0.6% market share in Secnidazole exports across 6 countries. The company exports 3 pharmaceutical products worth $715.5K across 2 therapeutic categories.
Zest Pharma — Secnidazole Export Profile: Buyers & Destinations

Where Does Zest Pharma Export Secnidazole?
| Country | Value | Shipments | Share |
|---|---|---|---|
| KENYA | $60.1K | 5 | 31.1% |
| CONGO | $26.3K | 2 | 13.7% |
| CONGO THE DEMOCRATIC REPUBLIC OF THE | $25.7K | 1 | 13.3% |
| CONGO D REPULIC | $25.4K | 1 | 13.2% |
| CONGO, THE DEMOCRATIC REPUBLIC OF THE | $15.4K | 1 | 8.0% |
| CONGO (KINSHASA) | $14.7K | 1 | 7.6% |
| TANZANIA | $12.8K | 1 | 6.6% |
| NIGERIA | $12.5K | 2 | 6.5% |
Zest Pharma exports Secnidazole to 8 countries. The largest destination is KENYA accounting for 31.1% of Zest Pharma's Secnidazole shipments, followed by CONGO (13.7%) and CONGO THE DEMOCRATIC REPUBLIC OF THE (13.3%). These destinations reflect Zest Pharma's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Secnidazole from Zest Pharma?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| UNIQUE PHARMA | CONGO (KINSHASA) | $94.4K | 5 |
| SYNER-MED PHARMACEUTICALS (KENYA)L | KENYA | $19.7K | 2 |
| SYNER MED PHARMACEUTICALS KENYA L | KENYA | $19.4K | 1 |
| SYNER-MED PHARMACEUTICALS (KENYA) L | KENYA | $15.5K | 1 |
| UNIQUE PHARMA, | CONGO, THE DEMOCRATIC REPUBLIC OF THE | $15.4K | 1 |
| SYNERMED (NIGERIA) LIMITED, | NIGERIA | $12.5K | 2 |
| UNIQUE PHARMA STE UNION DE | CONGO | $10.5K | 1 |
| SYNER-MED PHARMACEUTICALS (KENYA) | KENYA | $5.4K | 1 |
Zest Pharma supplies Secnidazole to 8 buyers globally. The largest buyer is UNIQUE PHARMA (CONGO (KINSHASA)), followed by SYNER-MED PHARMACEUTICALS (KENYA)L (KENYA) and SYNER MED PHARMACEUTICALS KENYA L (KENYA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Secnidazole Export Value and How Much Does Zest Pharma Contribute?
India exported $8.9M worth of Secnidazole through 652 shipments from 115 suppliers to 77 countries, serving 239 buyers globally. Zest Pharma contributes $192.9K to this total, accounting for 0.6% of India's Secnidazole exports. Zest Pharma ships Secnidazole to 8 countries through 8 buyers.
What Is the Average Shipment Value for Zest Pharma's Secnidazole Exports?
Zest Pharma's average Secnidazole shipment value is $13.8K per consignment, based on 14 shipments totaling $192.9K. The largest destination is KENYA (31.1% of Zest Pharma's Secnidazole exports).
How Does Zest Pharma Compare to Other Indian Secnidazole Exporters?
Zest Pharma ranks #11 among 115 Indian Secnidazole exporters with a 0.6% market share. The top 3 exporters are CAPLIN POINT LABORATORIES LIMITED ($2.1M), AJANTA PHARMA LIMITED ($2.0M), LINCOLN PHARMACEUTICALS LTD ($950.0K). Zest Pharma processed 14 shipments to 6 destination countries.
What Secnidazole Formulations Does Zest Pharma Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| (A)AZITHROMYCIN 1 GRAM (B) FLUCONAZOLE150MG (C) SECNIDAZOLE 2 GRAM TRIOKITB.NO.: TE4128 PACK :10X4 TAB | $25.7K | 1 |
| (a)Azithromycin 1gram,(b)Fluconazole 150mg,(c)Secnidazole 2gram(TRIOKIT),B.No. TE5003, PACK NO. 10x4 Tab, | $25.4K | 1 |
| TRIOKIT TAB A) AZITHROMYCIN DIHYDRATEUSP 1GR. B) FLUCONAZOLE 150MG. C)SECNIDAZOLE 1GR. | $19.7K | 2 |
| TRIOKIT TAB A AZITHROMYCIN DIHYDRATE USP 1GR. B FLUCONAZOLE 150MG. CSECNIDAZOLE 1GR. | $19.4K | 1 |
| aAzithromycin 1 gram b Fluconazole 150mg c Secnidazole 2 gram - TRIOKIT TAB B.NO: TE3271PACK: 10X4 | $15.8K | 1 |
| TRIOKIT TAB, A) AZITHROMYCIN DIHYDRATE USP 1GR. B) FLUCONAZOLE 150MG. C) SECNIDAZOLE 1GR. (2 TAB EACH IN A KIT) B.NO. TEKGS | $15.5K | 1 |
| (A)AZITHROMYCIN 1 GRAM,(B) FLUCONAZOLE 150MG,(C) SECNIDAZOLE 2 GRAM, (TRIOKIT),PACK: 10X4TAB, B.NO.: TE4064 | $15.4K | 1 |
| (A)AZITHROMYCIN 1 GRAM (B) FLUCONAZOLE150MG (C) SECNIDAZOLE 2 GRAM (TRIOKIT)PACK 10X4 TAB B.NO. TE3228 | $14.7K | 1 |
| TRIOKIT ( (A)AZITHROMYCIN 1 GRAM(B) FLUCONAZOLE 150MG C) SECNIDAZOLE 2 GRAM)NOS | $12.8K | 1 |
| AAZITHROMYCIN 1GRAM BFLUCONAZOLE 150MG C SECNIDAZOLE 2GRAMTRIOKITB/NO.TE3271PACK 10X4 TAB QTY IN PKT=NOS | $10.5K | 1 |
Zest Pharma exports 13 distinct Secnidazole formulations including tablets, capsules, syrups, and combination drugs. The top formulation is (A)AZITHROMYCIN 1 GRAM (B) FLUCONAZOLE150MG (C) SECNIDAZOLE with 1 shipments worth $25.7K.
How Does Zest Pharma Compare to Nearest Secnidazole Exporters?
Exporters ranked immediately above and below #11 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 9 | THE MADRAS PHARMACEUTICALS | $250.0K | 5 | 1 | $50.0K |
| 5 | CIPLA LIMITED | $200.0K | 4 | 1 | $50.0K |
| 11 | ZEST PHARMA ★ | $192.9K | 14 | 6 | $13.8K |
| 12 | ALICE PHARMA PRIVATE LIMITED | $187.1K | 11 | 2 | $17.0K |
| 13 | TRIDENT LIFELINE LIMITED | $152.5K | 10 | 2 | $15.2K |
Zest Pharma ranks #11 among 115 Indian Secnidazole exporters. Average shipment value of $13.8K compared to the market average of $77.0K. The closest competitors by value are THE MADRAS PHARMACEUTICALS and CIPLA LIMITED.
Which Indian Ports Ship Secnidazole Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 75 | 11.5% |
| SAHAR AIR | 59 | 9.0% |
| SAHAR AIR CARGO ACC (INBOM4) | 57 | 8.7% |
| JNPT/ NHAVA SHEVA SEA | 46 | 7.1% |
| DELHI AIR | 46 | 7.1% |
| JNPT | 34 | 5.2% |
| DELHI AIR CARGO ACC (INDEL4) | 31 | 4.8% |
| AHEMDABAD ICD | 22 | 3.4% |
What Other Advanced Antibiotics Products Does Zest Pharma Export?
Zest Pharma also exports these advanced antibiotics products. Each links to the detailed product page.
About Zest Pharma
Zest Pharma exports 3 products worth $715.5K. Beyond Secnidazole, top products include Tinidazole, Protein. View the complete Zest Pharma profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Secnidazole — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Secnidazole shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Zest Pharma matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 14 individual customs records matching Zest Pharma exporting Secnidazole, covering 13 formulations to 8 countries via 8 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 77+ countries, 239+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Secnidazole Export Data from Zest Pharma
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Zest Pharma's Secnidazole exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Zest Pharma
Full Company Profile →
3 products · $715.5K total trade · 2 categories
Secnidazole Stats
Company Overview
Top Products by Zest Pharma
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Zest Pharma.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Secnidazole. For current shipment-level data, contact TransData Nexus.